Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03085225
What this trial is testing

Trabectedin Combined With Durvalumab in Patients With Advanced Pretreated Soft-tissue Sarcomas and Ovarian Carcinomas.

Who this might be right for
Ovarian CarcinomaSoft Tissue Sarcoma
Institut Bergonié 40
Testing effectiveness (Phase 2)Ended earlyNCT00262925
What this trial is testing

Combination Chemotherapy and Alemtuzumab in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

Who this might be right for
Recurrent Adult Acute Lymphoblastic Leukemia
National Cancer Institute (NCI) 12
Early research (Phase 1)UnknownNCT05333276
What this trial is testing

Clinical Trial of the TQB3602 Capsule Combined With AK105 Injection in Patients With Advanced Cancers

Who this might be right for
Advanced Cancers
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 7
Early research (Phase 1)Study completedNCT03332576
What this trial is testing

Phase 1b Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPeritoneal Cancer
ImmunoVaccine Technologies, Inc. (IMV Inc.) 37
Not applicableStudy completedNCT00768976
What this trial is testing

Study of Patient Satisfaction With the Cancer Clinical Trial Experience

Who this might be right for
Cancer
Summa Health System 100
Post-approval studies (Phase 4)Ended earlyNCT00604968
What this trial is testing

Pegylated Liposomal Doxorubicin (Caelyx(R)) as Monotherapy in Elderly Patients With Locally Advanced and/or Metastatic Breast Cancer (Study P05059)

Who this might be right for
Breast Neoplasms
Merck Sharp & Dohme LLC 25
Not applicableLooking for participantsNCT07285668
What this trial is testing

Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic Malignancies

Who this might be right for
Hematologic Malignancies
University of Wisconsin, Madison 38
Not applicableLooking for participantsNCT05694650
What this trial is testing

Perceptions of Hospital Care at Home for Patients With Cancer: A Qualitative Study of Cancer Providers, Patients and Caregivers.

Who this might be right for
Cancer
M.D. Anderson Cancer Center 20
Early research (Phase 1)Study completedNCT00652691
What this trial is testing

Topotecan, High-Dose Cyclophosphamide, Carboplatin, and an Autologous Peripheral Blood Cell Transplant in Treating Patients With Recurrent Ovarian Cancer or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPeritoneal Cavity Cancer
Mayo Clinic 48
Testing effectiveness (Phase 2)Study completedNCT02169791
What this trial is testing

Nonmyeloablative Haploidentical Transplant Followed by MLN9708

Who this might be right for
Acute LeukemiaChronic LeukemiaMyelodysplastic Syndrome+2 more
Northside Hospital, Inc. 29
Large-scale testing (Phase 3)Ended earlyNCT03326674
What this trial is testing

Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC

Who this might be right for
Breast Cancer
Odonate Therapeutics, Inc. 685
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07497074
What this trial is testing

JSKN033 Combination Therapy in Subjects With Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
Jiangsu Alphamab Biopharmaceuticals Co., Ltd 78
Early research (Phase 1)Study completedNCT00532090
What this trial is testing

A Multiple Ascending Dose Study of R4733 in Patients With Advanced Solid Tumors.

Who this might be right for
Neoplasms
Hoffmann-La Roche 110
Testing effectiveness (Phase 2)Study completedNCT02428192
What this trial is testing

Nivolumab Alone or in Combination With Ipilimumab in Treating Patients With Advanced Uterine Leiomyosarcoma

Who this might be right for
Metastatic LeiomyosarcomaUnresectable LeiomyosarcomaUterine Corpus Leiomyosarcoma
National Cancer Institute (NCI) 20
Early research (Phase 1)Not Yet RecruitingNCT07170592
What this trial is testing

OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients

Who this might be right for
Treatment-Refractory Solid Tumors
Bionoxx Inc. 24
Early research (Phase 1)Study completedNCT05087992
What this trial is testing

Find the Best Dose of BI 905711 in Combination With Chemotherapy and to Test Whether This Dose Helps People With Advanced Gastrointestinal Cancers

Who this might be right for
Gastrointestinal Cancer, Metastatic
Boehringer Ingelheim 13
Post-approval studies (Phase 4)UnknownNCT01336192
What this trial is testing

Maintenance Gemcitabine in the Chinese Advanced Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Tongji University 240
Not applicableUnknownNCT04045392
What this trial is testing

Effects of Mediterranean Diet Based Intervention in Breast Cancer Patients

Who this might be right for
Breast CancerObesity
Gangnam Severance Hospital 78
Testing effectiveness (Phase 2)Study completedNCT02891811
What this trial is testing

Patients With Newly Diagnosed Multiple Myeloma Comparing KTd vs. KRd Induction Therapy and Investigating a K-mono Maintenance Strategy

Who this might be right for
Multiple Myeloma
Arbeitsgemeinschaft medikamentoese Tumortherapie 124
Early research (Phase 1)Study completedNCT04420871
What this trial is testing

Pharmacokinetic and Safety Comparison of Two Capecitabine Tablets in Patients With Colorectal or Breast Cancer

Who this might be right for
Patient Participation
The Affiliated Hospital of Qingdao University 48
Next Page